Pt Kalbe Farma Stock Market Value

PTKFF Stock  USD 0.1  0.00  0.00%   
PT Kalbe's market value is the price at which a share of PT Kalbe trades on a public exchange. It measures the collective expectations of PT Kalbe Farma investors about its performance. PT Kalbe is trading at 0.0951 as of the 1st of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0951.
With this module, you can estimate the performance of a buy and hold strategy of PT Kalbe Farma and determine expected loss or profit from investing in PT Kalbe over a given investment horizon. Check out PT Kalbe Correlation, PT Kalbe Volatility and PT Kalbe Alpha and Beta module to complement your research on PT Kalbe.
Symbol

Please note, there is a significant difference between PT Kalbe's value and its price as these two are different measures arrived at by different means. Investors typically determine if PT Kalbe is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PT Kalbe's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PT Kalbe 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PT Kalbe's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PT Kalbe.
0.00
11/01/2024
No Change 0.00  0.0 
In 30 days
12/01/2024
0.00
If you would invest  0.00  in PT Kalbe on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding PT Kalbe Farma or generate 0.0% return on investment in PT Kalbe over 30 days. PT Kalbe is related to or competes with Sanofi ADR, Bristol Myers, AstraZeneca PLC, Gilead Sciences, and Novartis. PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in In... More

PT Kalbe Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PT Kalbe's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PT Kalbe Farma upside and downside potential and time the market with a certain degree of confidence.

PT Kalbe Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for PT Kalbe's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PT Kalbe's standard deviation. In reality, there are many statistical measures that can use PT Kalbe historical prices to predict the future PT Kalbe's volatility.
Hype
Prediction
LowEstimatedHigh
0.010.102.94
Details
Intrinsic
Valuation
LowRealHigh
0.000.082.92
Details
Naive
Forecast
LowNextHigh
00.102.94
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.10.10.1
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as PT Kalbe. Your research has to be compared to or analyzed against PT Kalbe's peers to derive any actionable benefits. When done correctly, PT Kalbe's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in PT Kalbe Farma.

PT Kalbe Farma Backtested Returns

PT Kalbe Farma retains Efficiency (Sharpe Ratio) of -0.0663, which implies the firm had a -0.0663% return per unit of price deviation over the last 3 months. PT Kalbe exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PT Kalbe's market risk adjusted performance of (0.29), and Information Ratio of (0.11) to confirm the risk estimate we provide. The company owns a Beta (Systematic Risk) of 0.64, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PT Kalbe's returns are expected to increase less than the market. However, during the bear market, the loss of holding PT Kalbe is expected to be smaller as well. At this point, PT Kalbe Farma has a negative expected return of -0.19%. Please make sure to check PT Kalbe's standard deviation, as well as the relationship between the maximum drawdown and day median price , to decide if PT Kalbe Farma performance from the past will be repeated at some future date.

Auto-correlation

    
  0.00  

No correlation between past and present

PT Kalbe Farma has no correlation between past and present. Overlapping area represents the amount of predictability between PT Kalbe time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PT Kalbe Farma price movement. The serial correlation of 0.0 indicates that just 0.0% of current PT Kalbe price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test-0.27
Residual Average0.0
Price Variance0.0

PT Kalbe Farma lagged returns against current returns

Autocorrelation, which is PT Kalbe pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PT Kalbe's pink sheet expected returns. We can calculate the autocorrelation of PT Kalbe returns to help us make a trade decision. For example, suppose you find that PT Kalbe has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

PT Kalbe regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PT Kalbe pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PT Kalbe pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PT Kalbe pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

PT Kalbe Lagged Returns

When evaluating PT Kalbe's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PT Kalbe pink sheet have on its future price. PT Kalbe autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PT Kalbe autocorrelation shows the relationship between PT Kalbe pink sheet current value and its past values and can show if there is a momentum factor associated with investing in PT Kalbe Farma.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in PTKFF Pink Sheet

PT Kalbe financial ratios help investors to determine whether PTKFF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PTKFF with respect to the benefits of owning PT Kalbe security.